Schumann G, Bonora R, Ceriotti F, Clerc-Renaud P, Ferrero CA, Férard G, Franck PF, Gella FJ, Hoelzel W, Jørgensen PJ, Kanno T, Kessne A, Klauker R, Kristiansen N, Lessinger JM, Linsinger TP, Misaki H, Panteghini M, Pauwels J, Schimmel HG, Vialle A, Weidemann G, Siekmann L. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med. 2002 Jun;40(6):635-42. \[[PubMed: 12211662](https://pubmed.ncbi.nlm.nih.gov/12211662)\] 20. Lippi G, von Meyer A, Cadamuro J, Simundic AM. Blood sample quality. Diagnosis (Berl). 2019 Mar 26;6(1):25-31. \[[PubMed: 29794250](https://pubmed.ncbi.nlm.nih.gov/29794250)\] 21. Giavarina D, Lippi G. Blood venous sample collection: Recommendations overview and a checklist to improve quality. Clin Biochem. 2017 Jul;50(10-11):568-573. \[[PubMed: 28242283](https://pubmed.ncbi.nlm.nih.gov/28242283)\] 22. Simundic AM, Baird G, Cadamuro J, Costelloe SJ, Lippi G. Managing hemolyzed samples in clinical laboratories. Crit Rev Clin Lab Sci. 2020 Jan;57(1):1-21. \[[PubMed: 31603708](https://pubmed.ncbi.nlm.nih.gov/31603708)\] 23. Vivekanandan S, Swaminathan R. Clinically effective CK-MB reporting: how to do it? J Postgrad Med. 2010 Jul-Sep;56(3):226-8. \[[PubMed: 20739777](https://pubmed.ncbi.nlm.nih.gov/20739777)\] 24. Recommended method for the determination of creatine kinase in blood. Scand J Clin Lab Invest. 1976 Dec;36(8):711-23. \[[PubMed: 1031483](https://pubmed.ncbi.nlm.nih.gov/1031483)\] 25. Kanemitsu F, Okigaki T. Creatine kinase isoenzymes. J Chromatogr. 1988 Jul 29;429:399-417. \[[PubMed: 3062028](https://pubmed.ncbi.nlm.nih.gov/3062028)\] 26. Chen A, Wong SS. Differentiation of creatine kinase MB and IgA-linked BB isoenzymes on electrophoresis. FEBS Lett. 1987 Apr 06;214(1):192-4. \[[PubMed: 3494633](https://pubmed.ncbi.nlm.nih.gov/3494633)\] 27. Ogunro EA, Hearse DJ, Shillingford JP. Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res. 1977 Mar;11(2):94-102. \[[PubMed: 870200](https://pubmed.ncbi.nlm.nih.gov/870200)\] 28. Laurino JP, Fischberg-Bender E, Galligan S, Chang J. An immunochemical mass assay for the direct measurement of creatine kinase MB2. Ann Clin Lab Sci. 1995 May-Jun;25(3):252-63. \[[PubMed: 7605108](https://pubmed.ncbi.nlm.nih.gov/7605108)\] 29. Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta. 2004 Aug 16;346(2):211-9. \[[PubMed: 15256323](https://pubmed.ncbi.nlm.nih.gov/15256323)\] 30. Marwah SA, Shah H, Chauhan K, Trivedi A, Haridas N. Comparison of Mass Versus Activity of Creatine Kinase MB and Its Utility in the Early Diagnosis of Re-infarction. Indian J Clin Biochem. 2014 Apr;29(2):161-6. \[[PMC free article: PMC3990811](/pmc/articles/PMC3990811/)\] \[[PubMed: 24757297](https://pubmed.ncbi.nlm.nih.gov/24757297)\] 31. Seo H, Miyazaki S, Furuno T, Nonogi H, Haze K, Hiramori K. Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level. Jpn Heart J. 1993 Nov;34(6):717-27. \[[PubMed: 8164339](https://pubmed.ncbi.nlm.nih.gov/8164339)\] 32. Obzansky